Sensus Healthcare, Inc. (SRTS) stock
SRTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/3041% below fair value
$2.26−0.08 (-3.42%)
Close on Nov 17, 2026Market cap $37.20MP/E –Yield –
Sensus Healthcare operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Sensus Healthcare's operating income for the twelve months ending Sep 30, 2026 was -$12.31M. For fiscal 2025 it was -$10.31M, down 227.4% from the year before. The highest annual figure on record is $14.83M in fiscal 2022.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.31M | -227.4% |
| FY2024 | Dec 31, 2024 | $8.09M | – |
| FY2023 | Dec 31, 2023 | -$382.00K | -102.6% |
| FY2022 | Dec 31, 2022 | $14.83M | +260.0% |
| FY2021 | Dec 31, 2021 | $4.12M | – |
| FY2020 | Dec 31, 2020 | -$8.23M | – |
| FY2019 | Dec 31, 2019 | -$1.97M | – |
| FY2018 | Dec 31, 2018 | -$2.01M | – |
| FY2017 | Dec 31, 2017 | -$3.72M | – |
| FY2016 | Dec 31, 2016 | -$363.12K | – |
| FY2015 | Dec 31, 2015 | -$221.26K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$1.62M | – |
| Q2 FY2026 | Jun 30, 2026 | -$3.18M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.36M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.15M | -282.4% |
| Q3 FY2025 | Sep 30, 2025 | -$2.57M | -271.8% |
| Q2 FY2025 | Jun 30, 2025 | -$1.94M | -198.0% |
| Q1 FY2025 | Mar 31, 2025 | -$2.65M | -191.7% |
| Q4 FY2024 | Dec 31, 2024 | $1.73M | -69.1% |
| Q3 FY2024 | Sep 30, 2024 | $1.50M | – |
| Q2 FY2024 | Jun 30, 2024 | $1.98M | – |
| Q1 FY2024 | Mar 31, 2024 | $2.89M | – |
| Q4 FY2023 | Dec 31, 2023 | $5.58M | +33.7% |
| Q3 FY2023 | Sep 30, 2023 | -$1.90M | -187.7% |
| Q2 FY2023 | Jun 30, 2023 | -$1.13M | -124.7% |
| Q1 FY2023 | Mar 31, 2023 | -$2.94M | -174.8% |
| Q4 FY2022 | Dec 31, 2022 | $4.17M | -21.6% |
| Q3 FY2022 | Sep 30, 2022 | $2.16M | +1008.2% |
| Q2 FY2022 | Jun 30, 2022 | $4.57M | – |
| Q1 FY2022 | Mar 31, 2022 | $3.93M | – |
| Q4 FY2021 | Dec 31, 2021 | $5.32M | +1969.6% |
| Q3 FY2021 | Sep 30, 2021 | $195.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$279.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.12M | – |
| Q4 FY2020 | Dec 31, 2020 | $257.00K | -73.9% |
| Q3 FY2020 | Sep 30, 2020 | -$2.28M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.57M | -5759.3% |
| Q1 FY2020 | Mar 31, 2020 | -$3.64M | – |
| Q4 FY2019 | Dec 31, 2019 | $984.39K | +3049.7% |
| Q3 FY2019 | Sep 30, 2019 | -$805.13K | – |
| Q2 FY2019 | Jun 30, 2019 | $45.48K | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.19M | – |
| Q4 FY2018 | Dec 31, 2018 | $31.25K | – |
| Q3 FY2018 | Sep 30, 2018 | -$423.36K | – |
| Q2 FY2018 | Jun 30, 2018 | -$498.73K | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.11M | – |
| Q4 FY2017 | Dec 31, 2017 | -$399.51K | -2069.4% |
| Q3 FY2017 | Sep 30, 2017 | -$965.43K | – |
| Q2 FY2017 | Jun 30, 2017 | -$765.83K | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.59M | – |
| Q4 FY2016 | Dec 31, 2016 | $20.29K | – |
See a number that looks wrong?